| NEVADA                                                                                    |   | Commission      File No: |   | 87-0650264                                |
|-------------------------------------------------------------------------------------------|--------|--------------------------|--------|-------------------------------------------|
| (State      or other jurisdiction of incorporation or organization)                       |   | 000-32253                |   | (I.R.S.      Employer Identification No.) |
|                                                                                      |
| 16B/F      Ruixin Road Bldg. No. 25 Gaoxin Road Xi An 710075 Shaanxi Province,      China |
| (Address      of principal executive offices)                                             |
| (86)      29 8824 6358                                                                    |
| (Issuer's      telephone number, including areacode)                                      |

| Title of Each      Class of Equity Securities |   | Number of Shares Outstanding as of March 19,      2008 |
|-----------------------------------------------|--------|--------------------------------------------------------|
| Common      Stock, $0.018 par value           |   | 18,466,169                                             |

----

EXLANATORY NOTE

----

PARTI

----

PART III

| Exhibit      No. |   | Description                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|------------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1              |   | Articles      of Incorporation (1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.2              |   | Certificate      of Amendment to Articles of Incorporation (Incorporated by reference to      the exhibits to the Annual Report on Form 10-K filed on June 20, 2005.      )                                                                                                                                                                                                                                                                                                                                                             |
| 3.3              |   | Bylaws      of the Company (1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 4.1              |   | Secured      Convertible Promissory Note due and payable in full on December 30, 2009      (2)                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 4.2              |   | Form      of Warrant (2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.1             |   | Purchase      Agreement made as of October 27, 2006 among Xi’an Huifeng Biochemistry      Group Co., Ltd. and Shaanxi Pharmaceutical Chemical Facility Co., Ltd.      (Incorporated by reference to the exhibits to the Form 8-K filed on      October 31, 2006.)                                                                                                                                                                                                                                                                 |
| 10.2             |   | Securities      Purchase Agreement dated December 31, 2007 by and among Professional      Offshore Opportunity Fund, Peter Treadway, Janet Wang, Manilal Patel Ltd.,      Ancora Greater China Fund, Strategic Alliance Fund, L.P., and Strategic      Alliance Fund II, L.P. (2)                                                                                                                                                                                                                                                  |
| 10.3             |   | Registration      Rights Agreement dated December 31, 2007 by and among Professional      Offshore Opportunity Fund, Ltd., Peter Treadway, Janet Wang, Manilal      Patel, Ancora Greater China Fund, Strategic Alliance Fund, L.P., and      Strategic Alliance Fund II, L.P. (2)                                                                                                                                                                                                                                                      |
| 10.4             |   | Pledge      Agreement dated December 31, 2007 by and among Jing’an Wang, Junchao Wang      and Zhihua Zhang (collectively, the “Pledgors”),      Professional Offshore Opportunity Fund, Ltd., Peter Treadway, Janet Wang,      Manilal Patel, Ancora Greater China Fund, Strategic Alliance Fund, L.P.,      and Strategic Alliance Fund II, L.P. (collectively, the “Pledgee”) (2)                                                                                                                      |
| 10.5             |   | Pledge      Agreement dated as of December 31st, 2007 by and among Jing'an Wang,      Xinwen Hou, Junqi Zhang, Binjun Wang, Xugang Wang, and Zhilan Wang      (collectively, the “Pledgor ”),      Professional Offshore Opportunity Fund, Ltd., Peter Treadway, Janet Wang,      Manilal Patel, Ancora Greater China Fund, Strategic Alliance Fund, L.P.      and Strategic Alliance Fund II, L.P. (collectively, The “Pledgee ”) and      Northwest Biotechnic Inc., a British Virgin Islands corporation (2) |
| 21.1             |   | List      of Subsidiaries (Incorporated by reference to the exhibits to the      Registration Statement on Form SB-2 filed on January 30,    2008)                                                                                                                                                                                                                                                                                                                                                                                      |
| 31.1             |   | Sarbanes      Oxley Section 302 Certification of Chief Executive  Officer                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 31.2             |   | Sarbanes      Oxley Section 302 Certification of Chief Financial  Officer                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 32.1             |   | Sarbanes      Oxley Section 906 Certification of Chief Executive  Officer                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 32.2             |   | Sarbanes      Oxley Section 906 Certification of Chief Financial  Officer                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 99.1             |   | Code      of Ethics (3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|             |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| (1)              |   | Incorporated      by reference to the exhibits to the Registration Statement on Form SB-2      filed on July 28, 2000.                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (2)              |   | Incorporated      by reference to the exhibits to the Form 8-K filed on January 3,      2008.                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| (3)              |   | Incorporated      by reference from the Annual Report on Form 10-K filed on June 20,      2005.                                                                                                                                                                                                                                                                                                                                                                                                                                         |

----

SIGNATURES

|   |                                                |                        |
|--------|-----------------------------------------------------|-----------------------------|
|   | Huifeng      Bio-Pharmaceutical Technology, Inc.    |
|   |                                                |                        |
|   | By:                                            | /s/      Jing’an Wang |
|   | Jing’an      WangChief      Executive Officer |

|   |                                                                                |                 |
|--------|-------------------------------------------------------------------------------------|----------------------|
|   | By:                                                                            | /s/      Sanding Tao |
|   | Sanding      TaoChief      Financing Officer  Principal      Financial Officer |

| /s/ Jing’an Wang |   | Chairman      and Chief Executive Officer |   | January      20, 2009 |
|------------------------|--------|-------------------------------------------|--------|-----------------------|
|                   |   | (Principal      Executive Officer)        |   |                  |
|                   |   |                                      |   |                  |
| /s/      Sanding Tao   |   | Chief      Financing Officer              |   | January      20, 2009 |
|                   |   | (Principal      Financial Officer)        |   |                  |
|                   |   |                                      |   |                  |
| /s/      Xinwen Hou    |   | Director      and Secretary               |   | January      20, 2009 |